• Championing the Unowned Work in Healthcare That Closes the Loop on Patient Care with Angie Azevedo
    2026/11/09

    This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE

    Episode Overview:

    Some of the biggest breakthroughs in healthcare hide in the work nobody wants to own: the fifth follow-up call, the fax buried in a queue, the patient who slips between departments. And what looks like logistics is often a clinical problem in disguise.

    Our next guest, Angie Azevedo, is tackling this challenge as Principal Product Manager at Luma Health.

    Angie joined Luma as its fifth employee, when the team was literally working out of a rented closet, and she has helped shape its patient engagement tools ever since.

    Driven by a belief that healthcare should work for everybody, she now leads work on operational AI agents.

    Join us to hear how Angie and the Luma team are developing autonomous agents that are closing the loop on care for patients across the nation. Let's go!

    Episode Highlights:

    • Angie joined Luma as its fifth employee, working from a rented closet, and believed they were changing the world.
    • Healthcare can't settle for solving 80% of problems, because the remaining 20% are real patients needing care.
    • During COVID, Luma built virtual waiting rooms and supported Cook County vaccine deployment, proving healthcare operations can move fast.
    • Fax transformation hides clinical challenges inside logistics, and AI agents now automate documents, orders, referrals, and scheduling end to end.
    • An all-women product team speaks up for overlooked patients, from abuse clinics to teens needing privacy.

    About our Guest:

    Angie Shin Azevedo is a Staff Product Manager at Luma Health, leading product development on Luma's operational AI platform. Her work focuses on AI that closes gaps in patient access and care coordination, from fax transformation to outbound patient outreach to the EHR-integrated agents that coordinate both. Before Luma, Angie was at Reddit working on media foundations and content ranking. She grew up in California and now works out of Luma's Brazil R&D headquarters.

    Links Supporting This Episode:

    • Luma Health website: CLICK HERE
    • Angie (Shin) Azevedo LinkedIn page: CLICK HERE
    • Luma Health LinkedIn page: CLICK HERE
    • Mike Biselli LinkedIn page: CLICK HERE
    • Mike Biselli Twitter page: CLICK HERE
    • Visit our website: CLICK HERE
    • Subscribe to newsletter: CLICK HERE
    • Guest nomination form: CLICK HERE

    続きを読む 一部表示
    33 分
  • Shifting Healthcare Marketing From One-Time Patient Acquisition to Lifelong Loyalty
    2026/10/26

    This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE

    Episode Overview:

    Too many healthcare organizations spend heavily to win a patient once, then watch the relationship fade after a single visit. The real opportunity is turning those moments into continuous, trusted experiences that improve outcomes and lifetime value.

    Our next guest, Jordan Buning, is tackling this challenge as President of ddm marketing + communications.

    Over 28 years in marketing, Jordan began as a paid intern and now leads an agency built for highly complex, highly regulated industries.

    Driven by a belief in simplifying care for patients, he shares how proactive, personalized communication, smart marketing automation, and unexpected partnerships are reshaping healthcare engagement.

    Join us to discover how to cut through complexity, build lasting loyalty, and make the patient experience feel truly human. Let's go!

    Episode Highlights:

    • Marketing must reduce the distance between what healthcare knows and the world-class care experience patients actually receive.
    • Jordan started as a paid college intern and rose to president of ddm, cutting his teeth in healthcare.
    • Aspirational messaging is not enough anymore. Healthcare marketing must be performance driven, actionable, and give people useful information for decisions.
    • Retention is the overlooked opportunity. Using health record data responsibly can create lifelong patient relationships while honoring privacy.
    • Partnerships between startups, legacy systems, and insurers can lower costs for complex patients and change the healthcare ecosystem.

    About our Guest:

    Jordan Buning is President of ddm marketing + communications, a leading marketing agency for highly complex and highly regulated industries. Throughout Jordan's 28 years in marketing, he has served clients among a diverse range of industries, including healthcare, financial services and global manufacturing as well as public transportation, higher education, recreational products.

    Links Supporting This Episode:

    • ddm marketing + communications website: CLICK HERE
    • Jordan Buning LinkedIn page: CLICK HERE
    • ddm marketing + communications LinkedIn page: CLICK HERE
    • Mike Biselli LinkedIn page: CLICK HERE
    • Mike Biselli Twitter page: CLICK HERE
    • Visit our website: CLICK HERE
    • Subscribe to newsletter: CLICK HERE
    • Guest nomination form: CLICK HERE

    続きを読む 一部表示
    33 分
  • Connecting Wellbeing and Innovation to Fix Healthcare From the Inside Out
    2026/10/12
    This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: Healthcare innovation and associate wellbeing are too often treated as separate missions, but the most forward-thinking health systems know they must move together. Dr. Daniel Marchalik is proving exactly that as both Medical Director for Business Innovation and Executive Director of the Center for Wellbeing at MedStar Health's Institute for Innovation. A practicing urologist who also holds a Master's in Literature from Georgetown, Daniel brings a genuinely rare lens to this work, connecting the human experience of caregiving to the structural changes that actually move the needle. Leading a wellbeing strategy for over 36,000 associates while simultaneously driving venture and emerging technology initiatives, he and the MedStar team are redefining what a thriving healthcare workforce looks like. Join us to discover how innovation and wellbeing become one powerful force. Let's go!Episode Highlights:Dr. Marchalik's circuitous path, from English major to urologist to innovation leader, proves following curiosity pays off.MedStar's Center for Wellbeing lives inside the Innovation Institute, a uniquely powerful and rare structural decision.Fixing clinician burnout requires workflow redesign, not pizza parties, connecting wellbeing directly to innovation strategy.MedStar built an "inverse Swiss cheese model" for mental health support, so no employee can fall through the cracks.Innovators solving healthcare problems must involve clinicians at the table; their absence is immediately obvious and costly.About our Guest: Daniel Marchalik, MD, MBA is the Medical Director for Business Innovation in the MedStar Institute for Innovation. In this role, he oversees system venture, emerging technology and IP commercialization strategy.He also serves as the Executive Director of MedStar Health Center for Wellbeing which oversees the strategy and execution of wellbeing programming for over 36,000 associates across MedStar Health—the largest healthcare provider in the Mid-Atlantic region. The Center for Wellbeing drives associate engagement and retention through a focus on practice redesign, wellbeing culture improvement, and increased access to support services. He received his medical degree from the Rutgers Robert Wood Johnson School of Medicine, Masters in Business Administration from the University of Virginia Darden School of Business, and his Masters in Literature from Georgetown University. He is a Professor of Urology and Founding Director of the Literature and Medicine Track at the Georgetown University School of Medicine and is the author of a recurring medical humanities column in The Lancet. He directs the Kidney Stone Program at MedStar Washington Hospital Center and specializes in management of complex stone disease with a special focus on outpatient PCNLs. Links Supporting This Episode: MedStar Health website: CLICK HEREDr. Daniel Marchalik LinkedIn page: CLICK HEREMedStart Health LinkedIn page: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE
    続きを読む 一部表示
    31 分
  • Cracking the Code on GLP-1 Therapy, One Patient at a Time
    2026/09/28
    This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: Millions of people are prescribed GLP-1 medications only to quit within months, not because the medication doesn't work, but because standard dosing is setting them up to fail.Dr. Ian Justl Ellis, Founder, CEO, and Lead Physician at Voafit, has made it his mission to change that.As a board-certified emergency physician who personally gained sixty pounds during residency and later experienced both the promise and pitfalls of GLP-1 therapy firsthand, Dr. Ellis developed a precision-based approach that individualizes dosing down to the math.Through Voafit's proprietary MyLevel dosing engine, patients are finally achieving sustainable results without the side effects driving them away.Join us to discover how physician-supervised precision is transforming weight loss from a revolving door into a lasting breakthrough. Let's go!Episode Highlights:Dr. Ellis graduated residency 60 pounds overweight, despite decades of bodybuilding and personal training experience.Standard GLP-1 dosing causes medication accumulation, systematically overdosing patients and driving a 40 to 70 percent dropout rate.Voafit's precision MyLevel dosing engine delivered faster weight loss on less than half the standard medication dose, with zero patient dropout.One morbidly obese patient lost over 100 pounds using micro-dosed GLP-1 therapy, enabling two knee replacements and restored mobility.Dr. Ellis believes personalized GLP-1 dosing should become the standard of care, benefiting patients, clinicians, and pharmaceutical companies alike.About our Guest:Dr. Ian Justl Ellis is the Founder, CEO, and Lead Physician at Voafit. He specializes in helping individuals achieve their optimal physique while maintaining balance in their family, work, and social lives. His approach focuses on creating sustainable, real-world nutrition and exercise habits that can be maintained long-term without obsessive or unhealthy behaviors.Dr. Ellis has spent much of his life addressing what he describes as the "appetite problem." As a teenager determined not to follow the path of out-of-shape adults around him, he immersed himself in athletics, amateur bodybuilding, professional dance, and became a certified personal trainer. Despite achieving the desired outward appearance, he found himself caught in cycles of restriction, bingeing, and frustration.During medical school, marriage, and raising children simultaneously, he experienced significant personal weight gain and burnout, finishing residency sixty pounds overweight. In 2022, he was introduced to GLP-1 weight management medications, which helped address persistent hunger for the first time. However, using them in standard recommended dosing approaches resulted in muscle loss, weakness, and poor nourishment.In response, Dr. Ellis developed a precision-based approach to GLP-1 therapy that combines strength training, protein-first nutrition, hydration, and individualized dosing strategies. He also incorporated advanced peptide therapies to support hormonal optimization, muscle retention, and recovery.As a board-certified Emergency Physician, Dr. Ellis observed the risks of poorly managed GLP-1 and hormone therapies in clinical practice. He founded Voafit to provide physician-supervised precision dosing combined with individualized nutrition, exercise coaching, and advanced hormonal and peptide support.Dr. Ellis earned his M.D. from the University of Colorado, completed Emergency Medicine residency training at Mount Sinai Hospital in New York, and a fellowship in Medical Education. His background includes studies in Athletic Training, Biology, and Psychology, graduating summa cum laude.Today, he integrates his background in medicine, performance, and fitness to help patients achieve sustainable, long-term health outcomes through patient-centered care.Links Supporting This Episode: Voafit website: CLICK HEREDr. Ian Justl Ellis LinkedIn page: CLICK HEREVoafit Instagram page: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE
    続きを読む 一部表示
    40 分
  • Compounding Expertise, Amplifying Impact: Navigating AI's Role in the Future of Drug Discovery with Tara Austraat-Churik
    2026/09/14

    This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE

    Episode Overview:

    Breakthroughs in drug discovery don't come from any single discipline.

    They come from the rare few who have built deep expertise across multiple domains and know how to bring those layers together.

    Tara Austraat-Churik is doing exactly that as Partner at Blue Matter, where she leads the firm's first R&D practice at the intersection of drug discovery, clinical development, and AI-driven transformation.

    With a career spanning government intelligence, pharmacovigilance, IBM Watson Health, and Ernst Young, Tara has developed what she calls Compound Expertise, depth earned repeatedly across fields that compounds into judgment no single path can produce.

    Join us to discover how she and the Blue Matter team are helping biopharma organizations reimagine the future of R&D, navigate the AI transformation ahead, and keep the patient at the center of it all. Let's go!

    Episode Highlights:

    • Tara's "compound expertise" across government intelligence, IBM, EY, and pharma fuels her unique R&D consulting approach.
    • Blue Matter's R&D practice is built on scientific depth, AI-driven tools, and ecosystem partnerships, not generic consulting frameworks.
    • Tara predicts R&D workforces will shrink in headcount but grow in capability, with leaders managing both humans and AI agents.
    • The biggest AI transformation mistake: treating it as a technology problem rather than a decision-making transformation.
    • True client partnership happens when clients call for off-scope advice, trusting your judgment beyond any formal deliverable.

    About our Guest:

    Tara Austraat-Churik is a Partner at Blue Matter, where she leads the firm's R&D practice at the intersection of drug discovery, clinical development, and AI-driven transformation.

    Over a twenty-plus year career, she has built expertise across government intelligence, drug safety, enterprise technology, and life sciences — serving in roles including Acting General Manager of a $6 billion IBM consulting division and Managing Director of Health, Science, and Wellness at EY. She holds an MSc in Translational Medicine from the University of Edinburgh.

    Tara's work is guided by what she calls Compound Expertise: depth earned repeatedly across domains, compounding into the kind of judgment no single discipline can provide. She believes the most meaningful breakthroughs happen at the intersection of fields — and that each one represents a life that might be changed.

    Links Supporting This Episode:

    • Blue Matter page: CLICK HERE
    • Tara Austraat-Churik LinkedIn page: CLICK HERE
    • Blue Matter LinkedIn page: CLICK HERE
    • Mike Biselli LinkedIn page: CLICK HERE
    • Mike Biselli Twitter page: CLICK HERE
    • Visit our website: CLICK HERE
    • Subscribe to newsletter: CLICK HERE
    • Guest nomination form: CLICK HERE

    続きを読む 一部表示
    35 分
  • Bending the Cost Curve in Pediatric Healthcare with George Boghos
    2026/08/24
    This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: Children with special healthcare needs make up just 20% of the pediatric population, yet account for nearly half of all pediatric health spending, navigating a fragmented system that too often fails them. George Boghos, CEO of Imagine Pediatrics, is on a mission to change that. As a two-time founder with deep roots in pediatric care and healthcare investing, George brings both operational grit and genuine passion to this challenge. Under his leadership, Imagine Pediatrics has grown to serve more than 78,000 children across eight states, delivering 24/7 virtual and in-home medical, behavioral, and social care through value-based partnerships. Join us to discover how this pioneering model is keeping kids out of the hospital, building caregiver confidence, and proving that aligning incentives around outcomes transforms lives.Let's go!Episode Highlights:Imagine Pediatrics serves 78,000 children with special needs, delivering 24/7 virtual and in-home integrated care.George's mother, a retiring pediatrician, sparked his lifelong passion for reimagining pediatric healthcare from childhood.Just 20% of children with special needs account for over 50% of all pediatric healthcare spending nationally.In year one, Imagine Pediatrics saved $65 million in total cost of care across two health plan partnerships.With an NPS above 87, Imagine Pediatrics builds family trust by asking caregivers simply, "What keeps you up at night?About our Guest: Mr. Boghos manages overall operations and sets strategic direction for Imagine Pediatrics. He also leads the Impact arm of our organization, helping to expand our footprint and advance our ability to create a world where every child with special health care needs gets the care and support they deserve. Prior to Imagine Pediatrics, Mr. Boghos co-founded and led AIM Clinics, a center and in-home provider dedicated to delivering evidence-based Applied Behavioral Analysis (ABA) services to children with autism and their families who are from communities that experience health inequity. As CEO of AIM Clinics, Mr. Boghos was responsible for organizational growth and operational strategy. In four years, he led the company’s expansion from one clinic in Arkansas to more than 25 clinics spanning five states. In 2021, he oversaw AIM Clinics’ merger with Hopebridge Autism Therapy Centers — where he served as Chief Strategy Officer before joining the Clinical Advisory Board in 2023. As a current member of the board, Mr. Boghos remains deeply committed to the company’s vision of ensuring that all kids have access to comprehensive autism interventions at the highest level. Before dedicating his career to reimagining pediatric health care, Mr. Boghos trained in healthcare finance and investing, spending time at Primus Capital Funds, Baird Capital, and Citadel. He earned a B.A. in Economics and Mathematics from Vanderbilt University as well as an M.B.A. from the University of Chicago Booth School of Business. He currently resides in Chicago, Illinois with his family. Links Supporting This Episode: Imagine Pediatrics Website: CLICK HEREGeorge Boghos LinkedIn page: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form: CLICK HERE
    続きを読む 一部表示
    34 分
  • Disrupting the System, Defending the Dream of American Healthcare with Dr. Marschall Runge
    2026/08/10
    This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: American healthcare is at a crossroads, and the decisions we make now will define the health of generations to come.Dr. Marschall Runge has spent more than four decades at the center of that challenge, serving as former CEO of Michigan Medicine, Dean of the University of Michigan Medical School, and EVP for Medical Affairs.A practicing cardiologist trained at Johns Hopkins and Massachusetts General Hospital, Dr. Runge brings both the scientist's rigor and the leader's vision to one of the most urgent conversations of our time.In his Amazon and USA Today bestselling book, "The Great Healthcare Disruption," he lays out a bold prescription for reimagining American medicine through AI, innovation, and courageous systemic change.Join us to discover what it truly takes to transform healthcare from the inside out. Let's go!Episode Highlights:Dr. Runge never planned to be a CEO, initially dismissing healthcare leaders before serendipity shaped his path.His personal hospital-at-home experience after hip surgery confirmed that recovery is faster, cheaper, and better at home.Ambient AI, which auto-generates clinical notes, is the one decision at Michigan Medicine that faced almost no dissent.America's top-tier quaternary care leads the world; the real crisis is access, not quality.AI can address the clinician shortage in a year or two, something traditional training pipelines need decades to solve.About our Guest:Marschall S. Runge, M.D., Ph.D., was born in Austin, Texas, and graduated from Vanderbilt University with a BA in General Biology and a PhD in Molecular Biology. He received his medical degree from the Johns Hopkins School of Medicine and trained in internal medicine at Johns Hopkins Hospital. He was a cardiology fellow and junior faculty member at Massachusetts General Hospital. Dr. Runge’s next position was at Emory University, where he directed the Cardiology Fellowship Training Program. He then moved to the University of Texas Medical Branch in Galveston, where he was Chief of Cardiology and Director of the Sealy Center for Molecular Cardiology. He joined the University of North Carolina (UNC) from 2000 – 2014, where he served as Charles Addison and Elizabeth Ann Sanders Distinguished Professor of Medicine, Chair of the Department of Medicine, President of UNC Physicians and Vice Dean for Clinical Affairs.Dr. Runge is the former CEO of Michigan Medicine and Dean of the University of Michigan Medical School, and a practicing cardiologist. Dr. Runge is board-certified in internal medicine and cardiovascular diseases and has spoken and published widely on topics in clinical cardiology and vascular medicine.At the University of Michigan, Dr. Runge began serving as the executive vice president for medical affairs in March 2015 and, in January 2016, he was also appointed as the dean of the Medical School. He is the first person to serve in this combined position created by the Regents for the purpose of strengthening the integration between the Medical School and health care delivery in our hospitals and health centers.During his tenure in these leadership roles, Dr. Runge has implemented transformative change and positioned Michigan Medicine and the Medical School for continued success. Notable achievements during this period include: a significant expansion of Michigan Medicine’s clinical network in the state, through integration of two health systems, the former Metro Health in Grand Rapids and Sparrow Health System in Lansing, multiple joint ventures with Trinity Health, launch of the Precision Health Initiative, a major research collaboration with several other U-M schools and colleges; oversight of the conclusion of the Victors for Michigan campaign which raised $1.5 billion dollars for institutional strategic priorities; and the development and implementation of Michigan Medicine’s first strategic plan for diversity, equity and inclusion in support of the broader university-wide DEI initiative.Under Dr. Runge’s leadership, the University of Michigan Health’s adult hospitals were ranked best in Michigan in 2023-2024 in U.S. News & World Report “Best Hospitals” rankings, the 31st consecutive year that U-M Health has been nationally recognized for strong across-the-board performance. In Newsweek’s 2024 ranking of America’s Best Hospitals, U-M Health ranked #1 in the state and #3 in the country.Current and new initiatives under Dr. Runge’s leadership include construction of the The D. Dan and Betty Kahn Health Care Pavilion, a 12-story and 264 private room inpatient hospital; working to reduce faculty and staff burnout; executive rounding to help promote employee engagement and retention; establishment of the Heart Brain Institute and Global Health; oversight and development of the ...
    続きを読む 一部表示
    39 分
  • Closing the GLP-1 Post-Prescription Gap, One Shot at a Time with Aja Beckett
    2026/07/27

    This episode’s Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow’ Sustainability Campaign, and how you can get involved: CLICK HERE

    Episode Overview:

    Millions of people are prescribed GLP-1 medications and then left entirely on their own, navigating confusion, stigma, and unanswered questions with no structured support in sight.

    Aja Beckett, Founder and CEO of Shotsy, is closing that post-prescription gap from the inside out.

    As both an iOS engineer and a GLP-1 user herself, Aja brings a rare combination of technical depth and lived experience to one of healthcare's most urgent challenges.

    Having built her career across Apple, CNN, TED, and The New York Times, she now channels that expertise into Shotsy, the number one companion app helping users turn every injection into a step toward lasting change.

    Join us to discover how community-driven innovation, empathy, and thoughtful technology are making the GLP-1 journey feel less lonely and more empowering. Let's go!

    Episode Highlights:

    • Aja lost 90 pounds on GLP-1 medication, inspiring her to build Shotsy for others on the same journey.
    • Shotsy filled a real gap, gaining 50 beta testers in 90 minutes and earning revenue on day one.
    • The app normalizes the GLP-1 experience through celebratory design, reducing shame and loneliness for users.
    • Community-driven beta testing serves as Shotsy's product team, shaping features for a truly global audience.
    • Aja envisions Shotsy as the go-to companion for the full GLP-1 journey, prioritizing support over clinical replacement.

    About our Guest:

    Aja brings the rare perspective of being both an iOS engineer and a GLP-1 user, now leading one of the fastest-growing health apps in the space. Her journey in tech spans some of the industry's most influential companies, including Apple, CNN, TED, and The Athletic/The New York Times.

    As a founder, Aja created Civil, a groundbreaking platform that garnered attention from major publications like WIRED, The Guardian, and TechCrunch. Her approach to product development emphasizes community-driven innovation and user-centric design.

    Today, she's channeling her expertise into Shotsy, revolutionizing how people manage their GLP-1 medication journey through thoughtful technology and data-driven insights.

    Links Supporting This Episode:

    • Shotsy website page: CLICK HERE
    • Aja Beckett LinkedIn page: CLICK HERE
    • Shotsy LinkedIn page: CLICK HERE
    • Mike Biselli LinkedIn page: CLICK HERE
    • Mike Biselli Twitter page: CLICK HERE
    • Visit our website: CLICK HERE
    • Subscribe to newsletter: CLICK HERE
    • Guest nomination form: CLICK HERE

    続きを読む 一部表示
    28 分